Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Salgado Remigio

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medicina Clinica|December 4, 1993
[Nitric oxide and sepsis]J Gómez Jiménez, A Salgado Remigio
Medicina Clinica|July 7, 2001
[Severe sepsis and septic shock: crossroad of inflammation and coagulation]P Torrabadella de Reynoso, A Salgado Remigio
Medicina Clinica|July 28, 1999
[New treatments of severe sepsis. A scientific, economic, and ethical dilemma]P Torrabadella de Reynoso, A Salgado Remigio
Medicina Clinica|December 12, 1992
[Monoclonal antibodies in the treatment of sepsis and septic shock]P Torrabadella de Reynoso, A Salgado Remigio, R Peracaula Picart
Revista Clinica Espanola|January 1, 1993
[Guillain-Barre syndrome as initial manifestation of human immunodeficiency virus infection]X Peris Cuello, A Salgado Remigio, J Gómez Jiménez, et al.
Medicina Clinica|January 19, 1985
[Leukocytes labeled with indium-111-oxine. Our clinical experience in the localization of postsurgical abdominal abscesses]B Soriano Borrás, F Porta Biosca, A Salgado Remigio, et al.
Medicina Clinica|March 5, 1983
[Post-transfusional non-cardiogenic pulmonary edema]R Orriols Martínez, A Salgado Remigio, A Ribera Crusafont, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medicina Clinica|December 4, 1993
[Nitric oxide and sepsis]J Gómez Jiménez, A Salgado Remigio
Medicina Clinica|July 7, 2001
[Severe sepsis and septic shock: crossroad of inflammation and coagulation]P Torrabadella de Reynoso, A Salgado Remigio
Medicina Clinica|July 28, 1999
[New treatments of severe sepsis. A scientific, economic, and ethical dilemma]P Torrabadella de Reynoso, A Salgado Remigio
Medicina Clinica|December 12, 1992
[Monoclonal antibodies in the treatment of sepsis and septic shock]P Torrabadella de Reynoso, A Salgado Remigio, R Peracaula Picart
Revista Clinica Espanola|January 1, 1993
[Guillain-Barre syndrome as initial manifestation of human immunodeficiency virus infection]X Peris Cuello, A Salgado Remigio, J Gómez Jiménez, et al.
Medicina Clinica|January 19, 1985
[Leukocytes labeled with indium-111-oxine. Our clinical experience in the localization of postsurgical abdominal abscesses]B Soriano Borrás, F Porta Biosca, A Salgado Remigio, et al.
Medicina Clinica|March 5, 1983
[Post-transfusional non-cardiogenic pulmonary edema]R Orriols Martínez, A Salgado Remigio, A Ribera Crusafont, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Pageof 1